Home ETF List About

ETF Holdings Breakdown of TXG

Stock Name10X Genomics Inc
TickerTXG(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS88025U1097
LEI5493003Z6741WNLG7H43
TickerTXG(EUR) F

TXG institutional holdings

The following institutional investment holdings of TXG have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-20 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 21,523USD 282,812 10.0%
2025-10-20 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 135,789USD 1,784,267
2025-10-20 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 73,099USD 960,521
2025-10-20 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 73,099USD 960,521
2025-10-20 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 72,110USD 947,525
2025-10-20 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 546USD 7,174
Total =376,166 USD 4,942,820
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with TXG

TXG Crosses Above Average Analyst Target
In recent trading, shares of 10x Genomics Inc (Symbol: TXG) have crossed above the average analyst 12-month target price of $13.25, changing hands for $13.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valu - 2025-08-05 07:41:55

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.